<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d30">
    <sentence id="DDI-DrugBank.d30.s0" text="No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital.">
        <entity charOffset="98-116" id="DDI-DrugBank.d30.s0.e0" text="hydrochlorothiazide" type="drug"/>
        <entity charOffset="119-125" id="DDI-DrugBank.d30.s0.e1" text="digoxin" type="drug"/>
        <entity charOffset="128-135" id="DDI-DrugBank.d30.s0.e2" text="warfarin" type="drug"/>
        <entity charOffset="138-147" id="DDI-DrugBank.d30.s0.e3" text="cimetidine" type="drug"/>
        <entity charOffset="153-165" id="DDI-DrugBank.d30.s0.e4" text="phenobarbital" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e0" e2="DDI-DrugBank.d30.s0.e1" id="DDI-DrugBank.d30.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e0" e2="DDI-DrugBank.d30.s0.e2" id="DDI-DrugBank.d30.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e0" e2="DDI-DrugBank.d30.s0.e3" id="DDI-DrugBank.d30.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e0" e2="DDI-DrugBank.d30.s0.e4" id="DDI-DrugBank.d30.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e1" e2="DDI-DrugBank.d30.s0.e2" id="DDI-DrugBank.d30.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e1" e2="DDI-DrugBank.d30.s0.e3" id="DDI-DrugBank.d30.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e1" e2="DDI-DrugBank.d30.s0.e4" id="DDI-DrugBank.d30.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e2" e2="DDI-DrugBank.d30.s0.e3" id="DDI-DrugBank.d30.s0.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e2" e2="DDI-DrugBank.d30.s0.e4" id="DDI-DrugBank.d30.s0.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s0.e3" e2="DDI-DrugBank.d30.s0.e4" id="DDI-DrugBank.d30.s0.p9"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No significant &lt;/cue&gt; drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d30.s1" text="Rifampin, an inducer of drug metabolism, decreased the concentrations of losartan and its active metabolite.">
        <entity charOffset="0-7" id="DDI-DrugBank.d30.s1.e0" text="Rifampin" type="drug"/>
        <entity charOffset="73-80" id="DDI-DrugBank.d30.s1.e1" text="losartan" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d30.s1.e0" e2="DDI-DrugBank.d30.s1.e1" id="DDI-DrugBank.d30.s1.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s2" text="In humans, two inhibitors of P450 3A4 have been studied."/>
    <sentence id="DDI-DrugBank.d30.s3" text="Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration.">
        <entity charOffset="0-11" id="DDI-DrugBank.d30.s3.e0" text="Ketoconazole" type="drug"/>
        <entity charOffset="46-53" id="DDI-DrugBank.d30.s3.e1" text="losartan" type="drug"/>
        <entity charOffset="116-123" id="DDI-DrugBank.d30.s3.e2" text="losartan" type="drug"/>
        <entity charOffset="130-141" id="DDI-DrugBank.d30.s3.e3" text="erythromycin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e0" e2="DDI-DrugBank.d30.s3.e1" id="DDI-DrugBank.d30.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e0" e2="DDI-DrugBank.d30.s3.e2" id="DDI-DrugBank.d30.s3.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e0" e2="DDI-DrugBank.d30.s3.e3" id="DDI-DrugBank.d30.s3.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e1" e2="DDI-DrugBank.d30.s3.e2" id="DDI-DrugBank.d30.s3.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e1" e2="DDI-DrugBank.d30.s3.e3" id="DDI-DrugBank.d30.s3.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s3.e2" e2="DDI-DrugBank.d30.s3.e3" id="DDI-DrugBank.d30.s3.p5"/>
    <negationtags>Ketoconazole did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d30.s4" text="Fluconazole, an inhibitor of P450 2C9, decreased active metabolite concentration and increased losartan concentration.">
        <entity charOffset="0-10" id="DDI-DrugBank.d30.s4.e0" text="Fluconazole" type="drug"/>
        <entity charOffset="95-102" id="DDI-DrugBank.d30.s4.e1" text="losartan" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d30.s4.e0" e2="DDI-DrugBank.d30.s4.e1" id="DDI-DrugBank.d30.s4.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s5" text="The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined.">
        <entity charOffset="55-62" id="DDI-DrugBank.d30.s5.e0" text="losartan" type="drug"/>
    <negationtags>The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been examined. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d30.s6" text="Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9.">
        <entity charOffset="31-38" id="DDI-DrugBank.d30.s6.e0" text="losartan" type="drug"/>
    <negationtags>Subjects who do &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d30.s7" text="These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4.">
        <entity charOffset="42-49" id="DDI-DrugBank.d30.s7.e0" text="losartan" type="drug"/>
    <negationtags>These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; P450 3A4. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d30.s8" text="As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium.">
        <entity charOffset="81-107" id="DDI-DrugBank.d30.s8.e0" text="potassium-sparing diuretics" type="group"/>
        <entity charOffset="116-129" id="DDI-DrugBank.d30.s8.e1" text="spironolactone" type="drug"/>
        <entity charOffset="132-142" id="DDI-DrugBank.d30.s8.e2" text="triamterene" type="drug"/>
        <entity charOffset="145-153" id="DDI-DrugBank.d30.s8.e3" text="amiloride" type="drug"/>
        <entity charOffset="157-165" id="DDI-DrugBank.d30.s8.e4" text="potassium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e0" e2="DDI-DrugBank.d30.s8.e1" id="DDI-DrugBank.d30.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e0" e2="DDI-DrugBank.d30.s8.e2" id="DDI-DrugBank.d30.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e0" e2="DDI-DrugBank.d30.s8.e3" id="DDI-DrugBank.d30.s8.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e0" e2="DDI-DrugBank.d30.s8.e4" id="DDI-DrugBank.d30.s8.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e1" e2="DDI-DrugBank.d30.s8.e2" id="DDI-DrugBank.d30.s8.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e1" e2="DDI-DrugBank.d30.s8.e3" id="DDI-DrugBank.d30.s8.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e1" e2="DDI-DrugBank.d30.s8.e4" id="DDI-DrugBank.d30.s8.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e2" e2="DDI-DrugBank.d30.s8.e3" id="DDI-DrugBank.d30.s8.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e2" e2="DDI-DrugBank.d30.s8.e4" id="DDI-DrugBank.d30.s8.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s8.e3" e2="DDI-DrugBank.d30.s8.e4" id="DDI-DrugBank.d30.s8.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s9" text="As with other antihypertensive agents, the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin">
        <entity charOffset="14-36" id="DDI-DrugBank.d30.s9.e0" text="antihypertensive agents" type="group"/>
        <entity charOffset="70-77" id="DDI-DrugBank.d30.s9.e1" text="losartan" type="drug"/>
        <entity charOffset="101-136" id="DDI-DrugBank.d30.s9.e2" text="non-steroidal anti-inflammatory drug" type="group"/>
        <entity charOffset="138-149" id="DDI-DrugBank.d30.s9.e3" text="indomethacin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s9.e0" e2="DDI-DrugBank.d30.s9.e1" id="DDI-DrugBank.d30.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s9.e0" e2="DDI-DrugBank.d30.s9.e2" id="DDI-DrugBank.d30.s9.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s9.e0" e2="DDI-DrugBank.d30.s9.e3" id="DDI-DrugBank.d30.s9.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s9.e1" e2="DDI-DrugBank.d30.s9.e2" id="DDI-DrugBank.d30.s9.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d30.s9.e1" e2="DDI-DrugBank.d30.s9.e3" id="DDI-DrugBank.d30.s9.p4" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d30.s9.e2" e2="DDI-DrugBank.d30.s9.e3" id="DDI-DrugBank.d30.s9.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d30.s10" text="."/>
    <sentence id="DDI-DrugBank.d30.s11" text=""/>
</document>